Jose Antonio Alvarez

Dr. Jose Antonio Alvarez

Hospital Regional de Alta Especialidad del Bajío, Guanajuato City, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
JMJuan Macias
Juan Macias
VAVirginia Arreguin
Virginia Arreguin
JMJuan M. Munoz
Juan M. Munoz
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez
JMJuan L. Mosqueda
Juan L. Mosqueda
AMAlejandro Macias
Alejandro Macias

1 January 2014 in American Journal of Infection Control
Verified
Journal Article
Closed access
ACAlejandro Campos-Murguía
Alejandro Campos-Murguía
XLXimena León-Lara
Ximena León-Lara
JMJuan M. Muñoz
Juan M. Muñoz
AMAlejandro Macias
Alejandro Macias
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez

28 April 2022 in Medicina
Verified
Journal Article
Open access
PDF file
EGEduardo Guaní-Guerra
Eduardo Guaní-Guerra
BTBrenda Janet Torres
Brenda Janet Torres
Carolina Muñoz-CoronaCarolina Muñoz-Corona
Carolina Muñoz-Corona
JJJose Carlos Rodríguez Jiménez
Jose Carlos Rodríguez Jiménez
AMAlejandro Macias
Alejandro Macias
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez
Background and Objectives: An association between high red blood cell distribution width (RDW) and mortality has been found in several diseases, including infection and sepsis. Some studies have aimed at determining the association of elevated RDW with adverse prognosis in COVID-19, but its usefulness has not been well established. The objective of this study was to determine the accuracy of the RDW, measured at hospital admission and discharge, for predicting death in patients with COVID-19. Materials andMethods: An observational, retrospective, longitudinal, and analytical study was conducted in two different COVID-19 reference centers in the state of Guanajuato, Mexico. A total of 323 patients hospitalized by COVID-19 were included. Results: We found higher RDW levels at the time of hospital admission in the non-survivors group compared to levels in survivors (median = 13.6 vs. 13.0, p < 0.001). Final RDW levels were even higher in the deceased group when compared with those of survivors (median = 14.6 [IQR, 12.67–15.6] vs. 12.9 [IQR, 12.2–13.5], p < 0.001). For patients who died, an RDW > 14.5% was more common at the time of death than for patients who survived at the time of discharge (81 vs. 13 patients, p < 0.001; RR = 2.3, 95% CI 1.89–2.81). Conclusions: The RDW is an accessible and economical parameter that, together with other characteristics of the presentation and evolution of patients with COVID-19, can be helpful in determining the prognosis. An RDW that increases during hospitalization could be a more important mortality predictor than the RDW at hospital admission.

1 December 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
HCHilda I. Cervantes
Hilda I. Cervantes
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez
JMJuan M. Muñoz
Juan M. Muñoz
VAVirginia Arreguín
Virginia Arreguín
JMJuan L. Mosqueda
Juan L. Mosqueda
AMAlejandro Macias
Alejandro Macias

1 April 2017 in American Journal of Infection Control
Verified
Journal Article
Closed access
JMJovanna Martínez
Jovanna Martínez
JMJuan Macias
Juan Macias
VAVirginia Arreguín
Virginia Arreguín
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez
AMAlejandro Macias
Alejandro Macias
JMJuan L. Mosqueda-Gómez
Juan L. Mosqueda-Gómez

1 December 2016 in American Journal of Infection Control
Verified
Journal Article
Closed access
JMJuan Macias
Juan Macias
MAMildred F. Alvarez
Mildred F. Alvarez
VAVirginia Arreguin
Virginia Arreguin
JMJuan M. Muñoz
Juan M. Muñoz
AMAlejandro Macias
Alejandro Macias
Jose Antonio AlvarezJose Antonio Alvarez
Jose Antonio Alvarez